A podcast series by Zita Bauer and Jann Zosso by Zita Bauer and Jann Zosso About recovery from Long Covid
The series follows personal recovery stories and explores new perspectives from modern pain science, neurobiology and mind-body medicine. Expert voices include Paul Garner, Howard Schubiner, Silje Endresen Reme and Monica Greco, who speak in English.
So Long Covid
In spring 2020, Covid changed all of our lives. But for some people, the pandemic never really ends. Jasna and Jann become seriously ill with Long Covid, facing fatigue, brain fog, and major limitations in everyday life. The illness pushes them to their limits. Again and again, the question arises: how can life go on like this? But is the situation really as hopeless as it seems?
So Long Covid
Jann is seriously ill when Zita comes across a new explanation for Long Covid: what if the symptoms are not caused by irreversible damage, but by a dysregulated nervous system? The trail leads to surprising recovery stories, to new approaches from pain therapy, and to the crucial question: can recovery be possible?
So Long Covid
An Instagram video by Marlen Reusser and Jann's story spark an aha moment for Jasna. What lies behind the idea that our brain and nervous system can learn symptoms? We dive into the world of pain research and neuroplasticity. What sounds almost unbelievable at first becomes a powerful source of hope.
So Long Covid
What are concrete techniques for unlearning neuroplastic symptoms? Jann, Jasna, and Patricia begin to understand their symptoms in a new way and to respond to them differently. At the centre are approaches such as somatic tracking, visualization, and nervous system regulation. This path is demanding and requires courage and patience. On top of that, people affected are often left to cope on their own. And yet, something is beginning to change.
So Long Covid
Based on research, international exchange, and clinical experience, University Hospital Basel now works both interdisciplinarily and with a primarily neuroplastic understanding of Long Covid — with success. In doing so, the team is pioneering this approach in Switzerland. But why is this promising knowledge spreading only slowly, and why does it sometimes even meet with resistance? About medical paradigms, cultural norms, and change emerging in the spaces in between.
So Long Covid
What remains after the experience of falling ill with Long Covid and recovering from it? And: what would need to change so that many more people can recover — or not become so seriously ill in the first place? The potential of the neuroplastic approach reaches far beyond Long Covid. A shift in the treatment of chronic illness is long overdue — and it has already begun.